Company: ELV
Filing Date: 2025-09-08
Form Type: 424B3
Source: 0001193125-25-197796
Chunk: 78

Company: Elevance Health, Inc.
Filing Date: 2025-09-08
Form: 424B3
Chunk 78
---
 of our common stock, preferred stock or depositary shares representing shares of preferred stock. Warrants may be issued independently or together with any of the other securities offered by this prospectus that are offered by any prospectus supplement and may be attached to or separate from the securities offered by this prospectus. Each series of warrants will be issued under a separate warrant agreement to be entered into between us and a warrant agent specified in the applicable prospectus supplement. The warrant agent will act solely as our agent in connection with the warrants of such series and will not assume any obligation or relationship of agency or trust for or with any holders or beneficial owners of warrants. The applicable prospectus supplement will describe the following terms, where applicable, of the warrants in respect of which this prospectus is being delivered:

| • |     | the title of the warrants; |

| • |     | the aggregate number of the warrants; |

| • |     | the price or prices at which the warrants will be issued; |

| • |     | the currencies in which the price or prices of such warrants may be payable; |

| • |     | the designation, number and terms of the securities purchasable upon exercise of the warrants; |

| • |     | the designation and terms of the other securities offered by this prospectus with which the warrants are issued, 
 and the number of the warrants issued with each security offered by this prospectus;                             |

| • |     | the date, if any, on and after which the warrants and the related securities will be separately transferable; |

| • |     | the price or prices at which and currency or currencies in which the securities purchasable upon exercise of the 
 warrants may be purchased;                                                                                       |

| • |     | the date on which the right to exercise the warrants shall commence and the date on which that right shall 
 expire;                                                                                                    |

| • |     | the minimum or maximum amount of the warrants which may be exercised at any one time; |

| • |     | information with respect to book-entry procedures, if any; |

| • |     | a discussion of material U.S. federal income tax considerations; and |

| • |     | any other material terms of the warrants, including terms, procedures and limitations relating to the exchange 
 and exercise of the warrants.                                                                                  |

28

DESCRIPTION OF THE RIGHTS We may issue rights to our shareholders for the purchase of our common stock, preferred stock or depositary shares. Each series of rights will be issued under a